Oxford Cryosystems
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oxford Cryosystems - overview
Established
1985
Location
Oxford, -, UK
Primary Industry
Medical Devices & Equipment
About
Oxford Cryosystems is a UK-based company specializing in advanced cryogenic systems for scientific applications, focusing on providing innovative solutions for research in materials science and astrophysics. Founded in 1985, Oxford Cryosystems operates from its headquarters in Oxford, UK, developing advanced cryogenic solutions. The company has been involved in two significant deals, with the most recent occurring on October 5, 2015, when Catapult Ventures exited its stake to the management. The company was established by individuals with a strong background in cryogenics, though specific founder details are not provided.
Oxford Cryosystems specializes in advanced cryogenic solutions tailored for scientific research, focusing on applications like diffraction analysis and radio astronomy. Their core products include open-flow coolers, closed-cycle cryostats, and proprietary GM cryocoolers, designed to provide controlled environments for high-precision experiments. These systems facilitate rapid sample swapping and integrate well into vertical goniometers, enhancing research efficiency. Their clientele encompasses academic institutions and industry laboratories across Europe, North America, and Asia, involved in materials science, pharmaceuticals, and astrophysics.
In the most recent year 2023, Oxford Cryosystems reported a revenue of USD 10. 76 mn, with an EBITDA of USD 3. 15 mn. The company generates revenue through direct sales of cryogenic systems and support services, primarily engaging in B2B transactions with research institutions and laboratories.
Their pricing structures are based on the complexity and customization of equipment, with flagship products like the Cryostream and Cobra catering to diverse applications. Supplementary revenue is derived from service kits and maintenance offerings. Oxford Cryosystems aims to expand its product line with new developments in cryogenic technology, though specific new products and their release dates have yet to be disclosed. The company is also targeting expansion into emerging markets in Asia and North America by 2025.
The recent funding activities are expected to support these initiatives, enhancing R&D capabilities and market penetration. In October 2015, Catapult Ventures exited its investment through management, allowing the company to focus on its strategic growth initiatives.
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment
Website
www.oxfordcryosystems.co.uk
Verticals
Manufacturing
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.